Priority topics
The group undertook a priority setting exercise in 2020 which identified the following topics for new reviews as high priorities. Potential authors should check whether there is an existing up-to-date high-quality systematic review before submitting an expression of interest.
- Pharmacological therapies other than quinine and magnesium for muscle cramps
- Treatment for muscle pain in neuromuscular disease
- Interventions to improve quality of life/psychological interventions for carers of people with life-limiting neurological conditions [area of overlap with Cochrane Common Mental Disorders]
- Physiotherapy and splinting for the prevention of contractures [area of overlap with Cochrane Musculoskeletal]
- Liver transplantation for hereditary amyloid neuropathy
- Treatment for radiation plexopathy
- Surgical interventions for carpal tunnel syndrome: a network meta-analysis
- B vitamins for treating peripheral neuropathy
- Treatments for congenital myasthenia
- Serological, pharmacological, and electrophysiological tests for the diagnosis of myasthenia gravis (DTA review)
- FcRN inhibitors for myasthenia gravis
- Immunosuppressive agents for myasthenia gravis
- Cardiac management for myotonic dystrophy
- Cell-based and gene transfer therapies for dystrophinopathies
- Hydrotherapy for muscular dystrophy
- Disease-modifying drugs for central nuclear myopathies
- Percutaneous endoscopic gastrostomy for muscle diseases
- Gene therapy for spinal muscular atrophy
- Gene therapies for amyotrophic lateral sclerosis/motor neuron disease
- Percutaneous endoscopic gastrostomy versus endoscopic gastrostomy for people with amyotrophic lateral sclerosis/motor neuron disease
- Pharmacological interventions for improving respiratory symptoms and function in amyotrophic lateral sclerosis/motor neuron disease
List last updated 14/03/21